Fig. 1From: Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphomasIL-2R, MMP-2, and MMP-9 in patients with IOL and uveitis. Serum sIL-2R (A), and vitreous sIL-2R (B), MMP-2 (C), and MMP-9 (D) in patients with IOL and uveitis. *Pā<ā0.05; MannāWhitney U testBack to article page